Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP965694.RApIZLiN02c_L_K8AXB1u1_XnWyrB05zHaf1BSpgQEjn8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP965694.RApIZLiN02c_L_K8AXB1u1_XnWyrB05zHaf1BSpgQEjn8130_assertion type Assertion NP965694.RApIZLiN02c_L_K8AXB1u1_XnWyrB05zHaf1BSpgQEjn8130_head.
- NP965694.RApIZLiN02c_L_K8AXB1u1_XnWyrB05zHaf1BSpgQEjn8130_assertion wasGeneratedBy ECO_0000203 NP965694.RApIZLiN02c_L_K8AXB1u1_XnWyrB05zHaf1BSpgQEjn8130_provenance.
- NP965694.RApIZLiN02c_L_K8AXB1u1_XnWyrB05zHaf1BSpgQEjn8130_assertion wasDerivedFrom befree-20150227 NP965694.RApIZLiN02c_L_K8AXB1u1_XnWyrB05zHaf1BSpgQEjn8130_provenance.
- NP965694.RApIZLiN02c_L_K8AXB1u1_XnWyrB05zHaf1BSpgQEjn8130_assertion SIO_000772 16210338 NP965694.RApIZLiN02c_L_K8AXB1u1_XnWyrB05zHaf1BSpgQEjn8130_provenance.
- NP965694.RApIZLiN02c_L_K8AXB1u1_XnWyrB05zHaf1BSpgQEjn8130_assertion evidence source_evidence_literature NP965694.RApIZLiN02c_L_K8AXB1u1_XnWyrB05zHaf1BSpgQEjn8130_provenance.
- NP965694.RApIZLiN02c_L_K8AXB1u1_XnWyrB05zHaf1BSpgQEjn8130_assertion description "[The use of recombinant NK receptor ligands that target NK cells to tumor cells might offer new approaches for other malignancies provided a tumor antigen-specific antibody is available.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965694.RApIZLiN02c_L_K8AXB1u1_XnWyrB05zHaf1BSpgQEjn8130_provenance.